Sun Pharma Advanced Research Company reports standalone net loss of Rs 32.27 crore in the March 2017 quarter

Sales rise 1.04% to Rs 41.60 crore

Net Loss of Sun Pharma Advanced Research Company reported to Rs 32.27 crore in the quarter ended March 2017 as against net loss of Rs 9.58 crore during the previous quarter ended March 2016. Sales rose 1.04% to Rs 41.60 crore in the quarter ended March 2017 as against Rs 41.17 crore during the previous quarter ended March 2016.

For the full year,net loss reported to Rs 120.27 crore in the year ended March 2017 as against net loss of Rs 69.99 crore during the previous year ended March 2016. Sales rose 12.24% to Rs 181.02 crore in the year ended March 2017 as against Rs 161.28 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales41.6041.17 1 181.02161.28 12 OPM %-81.49-20.99 --68.41-39.18 - PBDT-30.19-7.62 -296 -112.03-62.41 -80 PBT-32.27-9.58 -237 -120.27-69.99 -72 NP-32.27-9.58 -237 -120.27-69.99 -72

Powered by Capital Market - Live News